Louis P Garrison

发表

The ISPOR Good Practice Modeling Principles--a sensible approach: be transparent, be reasonable.

Louis P Garrison, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].

Milton C Weinstein, Scott D Ramsey, Louis P Garrison, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].

Louis P Garrison, Anirban Basu, Patricia M Danzon, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].

Scott D Ramsey, Louis P Garrison, Peter J Neumann, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Universal health coverage--big thinking versus big data.

Louis P Garrison, L. Garrison, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].

Louis P Garrison, Peter J Neumann, Richard J Willke, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers.

Louis P Garrison, Sean D Sullivan, David L Veenstra, 2010, Health policy.

Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An Overview.

Louis P Garrison, L. Garrison, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.

Andrew Briggs, Louis P Garrison, Adrian Towse, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].

Louis P Garrison, Peter J Neumann, Richard J Willke, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.

Karl Claxton, Milton C Weinstein, Maarten J. IJzerman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer.

Louis P Garrison, David L Veenstra, L. Garrison, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.

Louis P Garrison, Sean D Sullivan, Kimberly Westrich, 2015, The American journal of managed care.

Global eradication of measles: an epidemiologic and economic evaluation.

Louis P Garrison, Colleen Burgess, Emily Simons, 2011, The Journal of infectious diseases.

Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis.

Louis P Garrison, Adrian Towse, L. Garrison, 2007, Health affairs.

Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis.

Louis P Garrison, Adrian Towse, L. Garrison, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests.

Scott D Ramsey, Louis P Garrison, Sean D Sullivan, 2006, The American journal of managed care.